Pharma Journalist -

Kato Pharmaceuticals announced that the FDA has approved the company's investigational new drug (IND) application to conduct human studies using Resolv ER for the treatment of…
Read More...

Paige,the global leader in AI-based diagnostic software in pathology, and Flagship Biosciences, a leader in data-centric pathology and tissue analysis, announced a partnership to…
Read More...

Agilent Technologies Inc. announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that…
Read More...

Ambrx Biopharma Inc., or Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, announced it…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Therapeutic Goods Administration (TGA) in Australia has granted…
Read More...

SMi Group reports: The 22nd Pain Therapeutics Conference welcomes The Pain Society and Eptiva Therapeutics to deliver keynote opening addresses Taking place on 4th to 5th May 2022 in…
Read More...

SwanBio Therapeutics, a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions, announced that the U.S. Food…
Read More...

Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company's investigational new drug (IND) application to…
Read More...

Breast cancer is a complex disease with many factors that influence whether the cancer will return or spread, yet few resources exist to help people diagnosed with breast cancer…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across six additional countries in…
Read More...